- Home
- BOLT vs TXMD Comparison
BOLT vs TXMD Comparison
Compare BOLT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- TXMD
- Stock Information
- Founded
- BOLT 2015
- TXMD 2008
- Country
- BOLT United States
- TXMD United States
- Employees
- BOLT N/A
- TXMD N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- BOLT Health Care
- TXMD Health Care
- Exchange
- BOLT Nasdaq
- TXMD Nasdaq
- Market Cap
- BOLT 10.4M
- TXMD 12.3M
- IPO Year
- BOLT 2021
- TXMD N/A
- Fundamental
- Price
- BOLT $5.75
- TXMD $1.25
- Analyst Decision
- BOLT Buy
- TXMD
- Analyst Count
- BOLT 3
- TXMD 0
- Target Price
- BOLT $47.50
- TXMD N/A
- AVG Volume (30 Days)
- BOLT 39.8K
- TXMD 449.4K
- Earning Date
- BOLT 11-11-2025
- TXMD 11-11-2025
- Dividend Yield
- BOLT N/A
- TXMD N/A
- EPS Growth
- BOLT N/A
- TXMD N/A
- EPS
- BOLT N/A
- TXMD N/A
- Revenue
- BOLT $4,167,000.00
- TXMD $2,559,000.00
- Revenue This Year
- BOLT N/A
- TXMD $427.09
- Revenue Next Year
- BOLT N/A
- TXMD N/A
- P/E Ratio
- BOLT N/A
- TXMD N/A
- Revenue Growth
- BOLT N/A
- TXMD 156.93
- 52 Week Low
- BOLT $4.59
- TXMD $0.70
- 52 Week High
- BOLT $14.36
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- BOLT 52.63
- TXMD 75.50
- Support Level
- BOLT $5.62
- TXMD $0.99
- Resistance Level
- BOLT $6.38
- TXMD $1.09
- Average True Range (ATR)
- BOLT 0.43
- TXMD 0.08
- MACD
- BOLT 0.01
- TXMD 0.01
- Stochastic Oscillator
- BOLT 41.53
- TXMD 36.62
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.